minodronic acid Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
calcium metabolism regulator, pharmaceutical aid 4074 180064-38-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • minodronic acid
  • minodronic acid hydrate
  • recalbon
  • minodronate
  • YM-529
  • YM529
  • Molecular weight: 322.15
  • Formula: C9H12N2O7P2
  • CLOGP: -2.09
  • LIPINSKI: 0
  • HAC: 9
  • HDO: 5
  • TPSA: 152.59
  • ALOGS: -1.57
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
July 11, 2011 PMDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Atypical femur fracture 70.68 30.61 17 911 4980 46680154
Osteonecrosis of jaw 65.98 30.61 25 903 34377 46650757
Spinal compression fracture 50.52 30.61 16 912 12887 46672247
Hepatic function abnormal 38.45 30.61 17 911 34404 46650730
Upper respiratory tract inflammation 31.85 30.61 8 920 2787 46682347
Osteomyelitis 31.40 30.61 13 915 22370 46662764

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event

Pharmacologic Action:

None

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Osteoporosis indication 64859006 DOID:11476

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.11 acidic
pKa2 6.18 acidic
pKa3 7.16 acidic
pKa4 10.96 acidic
pKa5 11.56 acidic
pKa6 5.65 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Farnesyl pyrophosphate synthase Enzyme IC50 8.52 CHEMBL
Geranylgeranyl pyrophosphate synthase Enzyme Ki 5.74 CHEMBL
Geranylgeranyl pyrophosphate synthase Enzyme Ki 6.89 CHEMBL
Farnesyl diphosphate synthase Enzyme IC50 5.96 CHEMBL

External reference:

IDSource
D09198 KEGG_DRUG
C0662880 UMLSCUI
M0N PDB_CHEM_ID
CHEMBL319144 ChEMBL_ID
DB06548 DRUGBANK_ID
3164 IUPHAR_LIGAND_ID
7651 INN_ID
40SGR63TGL UNII
130956 PUBCHEM_CID

Pharmaceutical products:

None